291 related articles for article (PubMed ID: 11218921)
1. Epidemiology of hepatocellular carcinoma.
el-Serag HB
Clin Liver Dis; 2001 Feb; 5(1):87-107, vi. PubMed ID: 11218921
[TBL] [Abstract][Full Text] [Related]
2. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma in cirrhosis: incidence and risk factors.
Fattovich G; Stroffolini T; Zagni I; Donato F
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S35-50. PubMed ID: 15508101
[TBL] [Abstract][Full Text] [Related]
4. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus-related complications are increasing in women veterans: A national cohort study.
Kramer JR; El-Serag HB; Taylor TJ; White DL; Asch SM; Frayne SM; Cao Y; Smith DL; Kanwal F
J Viral Hepat; 2017 Nov; 24(11):955-965. PubMed ID: 28815822
[TBL] [Abstract][Full Text] [Related]
6. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.
El-Serag HB; Richardson PA; Everhart JE
Am J Gastroenterol; 2001 Aug; 96(8):2462-7. PubMed ID: 11513191
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma: status in the era of liver transplantation.
Singhal A; Jabbour N
J Okla State Med Assoc; 2009 Dec; 102(12):355-61. PubMed ID: 20131731
[No Abstract] [Full Text] [Related]
8. Etiological factor of hepatocellular carcinoma in Italy.
Stroffolini T
Minerva Gastroenterol Dietol; 2005 Mar; 51(1):1-5. PubMed ID: 15756142
[TBL] [Abstract][Full Text] [Related]
9. Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Analysis of infectious hepatitis viruses.
Kato Y; Nakata K; Omagari K; Furukawa R; Kusumoto Y; Mori I; Tajima H; Tanioka H; Yano M; Nagataki S
Cancer; 1994 Oct; 74(8):2234-8. PubMed ID: 7922974
[TBL] [Abstract][Full Text] [Related]
10. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma: an epidemiologic view.
El-Serag HB
J Clin Gastroenterol; 2002; 35(5 Suppl 2):S72-8. PubMed ID: 12394209
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for the rising rates of primary liver cancer in the United States.
El-Serag HB; Mason AC
Arch Intern Med; 2000 Nov; 160(21):3227-30. PubMed ID: 11088082
[TBL] [Abstract][Full Text] [Related]
13. Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States.
Welzel TM; Graubard BI; Quraishi S; Zeuzem S; Davila JA; El-Serag HB; McGlynn KA
Am J Gastroenterol; 2013 Aug; 108(8):1314-21. PubMed ID: 23752878
[TBL] [Abstract][Full Text] [Related]
14. Incidence and risk factors for hepatocellular carcinoma in 967 patients with cirrhosis.
del Olmo JA; Serra MA; Rodríguez F; Escudero A; Gilabert S; Rodrigo JM
J Cancer Res Clin Oncol; 1998; 124(10):560-4. PubMed ID: 9829860
[TBL] [Abstract][Full Text] [Related]
15. The epidemiology of hepatocellular carcinoma.
Johnson PJ
Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):845-9. PubMed ID: 8889448
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics analysis of 1180 patients with hepatocellular carcinoma secondary to hepatitis B, hepatitis C and alcoholic liver disease.
Zhao H; Zhu P; Han T; Ye Q; Xu C; Wu L; Liu F; Yin W; Li Z; Guo Y
J Clin Lab Anal; 2020 Feb; 34(2):e23075. PubMed ID: 31659795
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma in western Sydney. Aetiology, changes in incidence, and opportunities for better outcomes.
Brotodihardjo AE; Tait N; Weltman MD; Liddle C; Little JM; Farrell GC
Med J Aust; 1994 Oct; 161(7):433-5. PubMed ID: 7935098
[TBL] [Abstract][Full Text] [Related]
18. Etiology of hepatocellular carcinoma in Argentina: results of a multicenter retrospective study.
Fassio E; Míguez C; Soria S; Palazzo F; Gadano A; Adrover R; Landeira G; Fernández N; García D; Barbero R; Perelstein G; Ríos B; Isla R; Civetta E; Pérez Ravier R; Barzola S; Curciarello J; Colombato LA; Jmeniltzky A
Acta Gastroenterol Latinoam; 2009 Mar; 39(1):47-52. PubMed ID: 19408739
[TBL] [Abstract][Full Text] [Related]
19. Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007.
Thein HH; Walter SR; Gidding HF; Amin J; Law MG; George J; Dore GJ
J Viral Hepat; 2011 Jul; 18(7):e232-41. PubMed ID: 21692938
[TBL] [Abstract][Full Text] [Related]
20. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
